Evidence map›Paper›PMID 42905887›Full record

ArticleHuman molecular genetics2026

KATNAL2 dysfunction impairs microtubule dynamics and contributes to syndromic neurodevelopmental disease.

Ece Sönmezler, Semra Hız Kurul, Ozlem Erez, Burcu Ekinci, Tutku Yaraş, Leman Binokay, Gökhan Karakülah, Hanns Lochmüller, Rita Horvath, Ahmet Yaramış and 2 more

Abstract read
In one paragraph

Article in Human molecular genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ece Sönmezlerİzmir International Biomedicine and Genome Institute, Dokuz Eylül University, Mithatpaşa Street No: 58/5, Balçova, İzmir 35340, Türkiye.ORCID 0000-0001-8526-1477
Semra Hız Kurulİzmir International Biomedicine and Genome Institute, Dokuz Eylül University, Mithatpaşa Street No: 58/5, Balçova, İzmir 35340, Türkiye.
Ozlem Erezİzmir Biomedicine and Genome Center, Mithatpaşa Street No: 58/5, Balçova, İzmir 35340, Türkiye.
Burcu Ekinciİzmir Biomedicine and Genome Center, Mithatpaşa Street No: 58/5, Balçova, İzmir 35340, Türkiye.
Tutku Yaraşİzmir Biomedicine and Genome Center, Mithatpaşa Street No: 58/5, Balçova, İzmir 35340, Türkiye.
Leman Binokayİzmir International Biomedicine and Genome Institute, Dokuz Eylül University, Mithatpaşa Street No: 58/5, Balçova, İzmir 35340, Türkiye.
Gökhan Karakülahİzmir International Biomedicine and Genome Institute, Dokuz Eylül University, Mithatpaşa Street No: 58/5, Balçova, İzmir 35340, Türkiye.
Hanns LochmüllerChildren's Hospital of Eastern Ontario Research Institute, 401 Smyth Road, Ottawa, ON K1H 8L1, Canada.
Rita HorvathDepartment of Clinical Neurosciences, University of Cambridge, John van Geest Centre for Brain Repair, Robinson Way CB2 0PY, Cambridge, United Kingdom.ORCID 0000-0002-9841-170X
Ahmet YaramışPediatric Neurology Clinic, Private Practice, Mahabad Boulevard, Kayapınar, Diyarbakır 21070, Türkiye.
Gulcin Cakan-Akdoganİzmir International Biomedicine and Genome Institute, Dokuz Eylül University, Mithatpaşa Street No: 58/5, Balçova, İzmir 35340, Türkiye.
Yavuz Oktayİzmir International Biomedicine and Genome Institute, Dokuz Eylül University, Mithatpaşa Street No: 58/5, Balçova, İzmir 35340, Türkiye.

Funding

European Union's Horizon 2020 research and innovation programme 952346Scientific and Technological Research Council of Turkey 120S404
6 · The paper itself

Abstract

Katanins are microtubule-severing ATPases. Dysfunction of katanin subunits has been implicated in impaired neurogenesis, morphogenesis, and neuronal migration. Although heterozygous variants in KATNAL2 (katanin-like 2), a known autism-spectrum disorder (ASD) risk gene, have been reported in patients with ASD or other neurodevelopmental disorders (NDD), the underlying cellular mechanisms remain incompletely defined. Whole-exome sequencing (WES) identified a homozygous missense variant in KATNAL2 (NM_001387690.1:c.1390T>C; p.(Ser464Pro)) in a pediatric patient presenting with severe global developmental delay, intellectual disability, infantile-onset epilepsy, and autistic features, extending the phenotypic spectrum beyond prior autism-focused associations. To elucidate the cellular mechanisms underlying KATNAL2 dysfunction, we established induced pluripotent stem cells (iPSCs) from patient fibroblasts and differentiated them into neural progenitor cells (NPCs) for quantitative immunofluorescence analyses of microtubule organization, microtubule regulatory proteins, and transcriptome profiling. In parallel, we generated CRISPR/Cas9 katnal2 zebrafish crispants and assessed body patterning and axonal projections using the transgenic nbt:dsRed line. Patient iPSC-derived NPCs showed impaired interphase microtubule network organization with increased angular standard deviation in directionality and mitotic/cytokinetic abnormalities, including abnormal positioning of the microtubule-rich cytokinetic midbody region. In vivo, CRISPR/Cas9 katnal2 zebrafish crispants showed abnormal body patterning together with disorganized motor neuron and posterior lateral line nerve axonal projections. Together, these findings support KATNAL2 as a regulator of microtubule network organization and mitotic progression in human NPCs. Our data from patient-derived NPCs and a zebrafish model provide functional evidence linking the p.(Ser464Pro) variant to an expanded syndromic neurodevelopmental phenotype.

Indexed as

KataninMicrotubulesNeurodevelopmental DisordersAnimalsAutism Spectrum DisorderExome SequencingFemaleHumansInduced Pluripotent Stem CellsIntellectual DisabilityMaleMutation, MissenseNeural Stem CellsZebrafishKataninautism spectrum disorderCRISPR-Cas9disease modelingiPSC modelneurogenetics

Identifiers

PMID42905887
PMCPMC13685775

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.